Emer Leahy

President & Chief Executive Officer at Psychogenics, Inc.

Emer Leahy

Emer Leahy

President & Chief Executive Officer at Psychogenics, Inc.

Overview
Career Highlights

Psychogenics, Inc.

RelSci Relationships

551

Number of Boards

6

Contact Data
Trying to get in touch with Emer Leahy? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Emer Leahy likely has professional access to. A relationship does not necessarily indicate a personal connection.

Adjunct Faculty Member, Department of Psychiatry at Yale University - Yale School of Medicine

Relationship likelihood: Strong

Founder & Chief Executive Officer at Intensity Therapeutics, Inc.

Relationship likelihood: Strong

Director at Psychogenics, Inc.

Relationship likelihood: Strong

Director at Psychogenics, Inc.

Relationship likelihood: Strong

Former Venture Partner at Third Rock Ventures LLC

Relationship likelihood: Strong

President & Chief Executive Officer at NeuroAssets Sarl

Relationship likelihood: Strong

Executive Director, Evidence-Based Toxicology Collaboration at Johns Hopkins Bloomberg School of Public Health

Relationship likelihood: Strong

Chairman, Department of Neuroscience at Icahn School of Medicine at Mount Sinai

Relationship likelihood: Strong

Owner at Psychogenics, Inc.

Relationship likelihood: Strong

General Counsel at Psychogenics, Inc.

Relationship likelihood: Strong

Paths to Emer Leahy
Potential Connections via
Relationship Science
You
Emer Leahy
President & Chief Executive Officer at Psychogenics, Inc.
Education
Ph.D. in Neuropharmacology

University College Dublin is one of Europe's leading research-intensive universities. At UCD undergraduate education, master's and PhD training, research, innovation and community engagement form a dynamic spectrum of activity. Today UCD is Ireland's largest and most diverse university with over 30,000 students, drawn from approximately 124 countries. It actively promotes university life as a journey of intellectual and personal discovery through its highly innovative and flexible UCD Horizons undergraduate curriculum and is the most popular destination for Irish school-leavers.

MBA

Columbia Business School (CBS) is the business school of Columbia University in Manhattan, New York City. It was established in 1916 to provide business training and professional preparation for undergraduate and graduate Columbia University students. It is one of six Ivy League business schools and its admission process is among the most selective of top business schools.

Career History
President & Chief Executive Officer
Current

Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ.

Executive Officer
Tenure Unconfirmed

Psylin Neurosciences, Inc. discovers and develops peptide hormones for the treatment of psychiatric disorders. The firm is formed in partnership between Amylin Pharmaceuticals, Inc. and PsychoGenics, Inc. The company was founded on January 30, 2007 and is located in San Diego, CA

Senior Vice President, Business Development
Prior

USA Equities Corp. operates as an holding company, which focuses on value-based healthcare, informatics and algorithmic personalized medicine including digital therapeutics, behaviour based remote patient monitoring, chronic care and preventive medicine. Its properties, products and information service development portfolio are directed towards prevention, early detection, management and reversal of cardiometabolic diseases. The company was founded on September 1, 1983 and is headquartered in West Palm Beach, FL.

Boards & Committees
Member, Business Advisory Board
Current

The Alzheimer’s Drug Discovery Foundation was established in 2004 as a public charity to support the advancement of drugs to prevent, treat, and cure Alzheimer’s disease, related dementias, and cognitive aging. This strategy of venture philanthropy is based on the idea that research grant recipients are engaged in projects that are potentially viable in the marketplace with a possible return on investment.

Member, Scientific Advisory Board
Current

To fund research aimed at potential cures for Rett syndrome and to empower families through education

Member, Emerging Companies Section Governing Board
Prior - 2015

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Transactions
Details Hidden

Psylin Neurosciences, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Emer Leahy. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Emer Leahy's profile does not indicate a business or promotional relationship of any kind between RelSci and Emer Leahy.